Annual report pursuant to Section 13 and 15(d)

Note 24 - Segment Information

v3.8.0.1
Note 24 - Segment Information
12 Months Ended
Dec. 31, 2017
Notes  
Note 24 - Segment Information

Note 24 – Segment Information

 

The Company is operating an acquisition and investment business. Majority owned subsidiaries of 51% or more are consolidated. The Company has determined that there are two reportable segments: 1) the cannabis and medical marijuana segment which includes the receivable from Bhang, the fair value of securities investment in GW Pharmaceuticals plc (GWPH) stock, Investment in Kush Bottles, Inc (KSHB) stock, the equity investment in Electrum, convertible notes receivables from Electrum and NeuCourt, the notes receivable from GFarma, the contractual interest in the G Farma legal recovery, and the operation of subsidiaries in the Cannabis and medical marijuana sector, and 2) the Company’s legacy investment in WCI which works with business park owners, governmental centers, and apartment complexes to reduce their facility related operating costs. The Company also has certain small cancer related legacy investments and an investment in note receivable from a non-affiliated party that is included in the Corporate and Eliminations section below.

 

 

 

Cannabis and

Medical

Marijuana

Segment

Trash

Management

Corporate

and

Eliminations

Consolidated

2017

 

Net sales

$

15,400

$

3,167,300

$

-

$

3,182,700

Operating income (loss)

 

(17,414)

130,066

(1,323,163)

(1,210,511)

Interest income

 

49,664

 

5

 

687,915

 

737,584

Interest Expense

 

-

19,429

54,033

73,462

Total assets

 

3,906,978

1,168,171

2,588,785

7,663,934

Property additions

 

-

6,622

13,815

20,437

Depreciation and amortization

 

-

11,123

4,583

15,706

 

 

 

Cannabis and

Medical

Marijuana

Segment

Trash

Management

Corporate

and

Eliminations

Consolidated

2016

 

 

 

 

 

 

 

 

Net sales

$

20,450

$

2,740,187

$

608

$

2,761,245

Operating income (loss)

 

(50,043)

34,485

(880,416)

(895,974)

Interest income

 

10,958

 

1

 

103,877

 

114,836

Interest Expense

 

-

17,275

23,350

40,625

Total assets

 

1,632,055

1,119,407

2,627,137

5,378,599

Property additions

 

-

29,210

1,029

30,239

Depreciation and amortization

 

295

21,752

3,715

25,762

 

The following table reconciles operating segments and corporate-unallocated operating income (loss) to consolidated income before income taxes for the years ended December 31, 2016 and 2015, as presented in the consolidated income statements:

 

 

 

2017

 

2016

Operating loss

$

(1,210,511)

$

(895,974)

Interest income

 

737,584

 

114,836

Interest Expense

 

(73,462)

 

(40,625)

Realized gain (loss) on investments

 

(164,590)

 

(42,289)

Gain (loss) on equipment disposals

 

-

 

11,568

Other income

 

5,036

 

9,143

Income before income taxes

$

(705,943)

$

(843,341)